British Columbia Investment Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

British Columbia Investment Management’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-76,398	Closed	-$1.34M	–	864
2021 Q3	$1.34M	Sell	76,398 -368,157	-83%	-$4.3M	0.01%	772
2021 Q2	$4.31M	Sell	444,555 -26,348	-6%	-$248K	0.03%	475
2021 Q1	$5.04M	Sell	470,903 -20,634	-4%	-$255K	0.04%	390
2020 Q4	$7.23M	Buy	491,537 +316,144	+180%	+$4.56M	0.05%	290
2020 Q3	$2.49M	Buy	+175,393	New	+$1.75M	0.02%	525

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

British Columbia Investment Management's TRIL Position: Q4 2021 in Review

British Columbia Investment Management sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 76,398 shares — an estimated $1.34M sold.

British Columbia Investment Management first reported a position in TRIL in Q3 2020 and held it in 5 quarters. The position peaked at $7.23M in Q4 2020. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

British Columbia Investment Management reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
British Columbia Investment Management sold 76,398 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $1.34M.
British Columbia Investment Management first reported a position in Trillium Therapeutics Inc. in Q3 2020 and held it in 5 quarters.
British Columbia Investment Management's Trillium Therapeutics Inc. position peaked at $7.23M in Q4 2020.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on British Columbia Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.